Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...

For the first time, scientists have grown functional, brain-like tissue without using any animal-derived materials or added ...

The 2025 Salmon Summit: Reconnecting Habitat, Restoring Rivers and Recovering Salmon was an impressive, one-day demonstration ...

With fresh tax relief and accelerating AI breakthroughs, select U.S. biotechs are entering a rare period of asymmetric upside ...

Avalo deploys interpretable machine learning (IML) to develop more climate resilient varieties of crops such as sugarcane and ...

Pluristyx's platform technology was developed specifically to overcome this challenge. This Breakthrough T1D collaboration will fund the use of precise gene editing to engineer Pluristyx's exclusively ...

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...

Researchers at the University of California San Diego School of Medicine have identified a promising new therapy for ...

OpenAI chief executive Sam Altman and his husband are now backing a contentious new venture that intends to use genetic engineering on babies to eliminate inherited diseases. The start-up, Preventive, ...

An Essex couple have become first to heat their home using a data centre stacked with computers in their garden shed ...

A Space Odyssey and Gattaca are among the best examples of 20th-century hard sci-fi, grounding their plots in logic and plausibility.

Sam Altman is backing a startup that’s trying to make disease-free babies through gene editing in countries with loose laws.